Evaluation of complementary effect of traditional medicine formulation to Category II regime in Tuberculosis (TB) treatment

Phase 3

• Conditions: Tuberculosis; Alternative and Complementary Medicine - Herbal remedies; Infection - Other infectious diseases

• Registration Number: ACTRN12613000834752
• Lead Sponsor: WHO (Technical service agreement)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-07-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Sputum smear positive patients at the start of Cat II regime at TB centres under National Tuberculosis Control Programme

Exclusion Criteria

a)Severe liver, kidney and/or bone marrow disorders as diagnosed by medical officer based on biochemical laboratory tests (Blood for complete picture, liver function tests, renal function tests)
b)History of diabetes, hypertension, hepatitis B infection, hepatitis C infection, HIV
c)History of taking steroids or anti-cancer drugs within one month
d)Acute medical or surgical complications which require hospitalization
e)Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified